Literature DB >> 27660516

Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis.

Yvan Jamilloux1,2, Delphine Maucort-Boulch3,4,2, Sébastien Kerever5,6, Mathieu Gerfaud-Valentin7, Christiane Broussolle7, Mireille Eb8, Dominique Valeyre9,2, Pascal Seve7,2.   

Abstract

We evaluated mortality rates and underlying causes of death among French decedents with sarcoidosis from 2002 to 2011.We used data from the French Epidemiological Centre for the Medical Causes of Death to 1) calculate sarcoidosis-related mortality rates, 2) examine differences by age and gender, 3) determine underlying and nonunderlying causes of death, 4) compare with the general population (observed/expected ratios), and 5) analyse regional differences.1662 death certificates mentioning sarcoidosis were recorded. The age-standardised mortality rate was 3.6 per million population and significantly increased over the study period. The mean age at death was 70.4 years (versus 76.2 years for the general population). The most common underlying cause of death was sarcoidosis. Sarcoidosis decedents were more likely to be males when aged <65 years. When sarcoidosis was the underlying cause of death, the main other mentions on death certificates were chronic respiratory and cardiovascular diseases. The overall observed/expected ratio was >1 for infectious disease, tuberculosis and chronic respiratory disease, and <1 for neoplasms. We observed a north-south gradient of age-standardised mortality ratio at the country level.Despite the limitation of possibly capturing the more severe cases of sarcoidosis, this study may help define and prioritise preventive interventions.
Copyright ©ERS 2016.

Entities:  

Mesh:

Year:  2016        PMID: 27660516     DOI: 10.1183/13993003.00457-2016

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

1.  Multiple cause of death analysis in multiple sclerosis: A population-based study.

Authors:  Katharine Harding; Feng Zhu; Mohammed Alotaibi; Thomas Duggan; Helen Tremlett; Elaine Kingwell
Journal:  Neurology       Date:  2020-01-13       Impact factor: 9.910

2.  Mortality associated with Behçet's disease in France assessed by multiple-cause-of-death analysis.

Authors:  Emmanuelle David; Mathieu Fauvernier; David Saadoun; Mathieu Gerfaud-Valentin; Delphine Maurcort-Boulch; Pascal Sève; Yvan Jamilloux
Journal:  Clin Rheumatol       Date:  2022-01-29       Impact factor: 2.980

3.  Mammary sarcoidosis: A rare case report.

Authors:  Meriem Rhazari; Abdelbassir Ramdani; Sara Gartini; Siham Bouali; Mohammed Aharmim; Afaf Thouil; Hatim Kouismi; Jamal Eddine Bourkadi
Journal:  Ann Med Surg (Lond)       Date:  2022-05-31

4.  Sarcoidosis and increased risk of comorbidities and mortality in sweden.

Authors:  Johanna Larsson; Pål Graff; Ing-Liss Bryngelsson; Per Vihlborg
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-06-30       Impact factor: 0.670

5.  Prospective study of body mass index and risk of sarcoidosis in US women.

Authors:  Orianne Dumas; Krislyn M Boggs; Yvette C Cozier; Meir J Stampfer; Carlos A Camargo
Journal:  Eur Respir J       Date:  2017-10-19       Impact factor: 16.671

Review 6.  Epidemiology of sarcoidosis: current findings and future directions.

Authors:  Elizabeth V Arkema; Yvette C Cozier
Journal:  Ther Adv Chronic Dis       Date:  2018-08-24       Impact factor: 5.091

7.  Cardiac Involvement in Sarcoidosis Deaths in Wayne County, Michigan: A 20-Year Retrospective Study.

Authors:  Milad Webb; Kyle S Conway; Martin Ishikawa; Francisco Diaz
Journal:  Acad Forensic Pathol       Date:  2018-08-31

8.  Sarcoidosis mortality in Sweden: a population-based cohort study.

Authors:  Marios Rossides; Susanna Kullberg; Johan Askling; Anders Eklund; Johan Grunewald; Elizabeth V Arkema
Journal:  Eur Respir J       Date:  2018-02-21       Impact factor: 16.671

9.  Trends in systemic sclerosis and systemic sclerosis-related pulmonary arterial hypertension mortality in the USA.

Authors:  Pailin Ratanawatkul; Joshua J Solomon; Darlene Kim; Marjorie P George; Lia R Matarrese McGibbon; M Kristen Demoruelle; Mehrnaz Maleki-Fischbach; Isabelle Amigues; Liudmila Kastsianok; Evans R Fernández Pérez
Journal:  ERJ Open Res       Date:  2020-06-15

Review 10.  Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art.

Authors:  Francesca Polverino; Elisabetta Balestro; Paolo Spagnolo
Journal:  J Clin Med       Date:  2020-07-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.